Genomma Lab Internacional, S.A.B. de C.V. LABB.MX · Stock Open Genomma Lab Internacional, S.A.B. de C.V. in new tab
Genomma Lab Internacional, S.A.B. de C.V. Analysis (LABB.MX)
Is Genomma Lab Internacional, S.A.B. de C.V. a good investment? Genomma Lab Internacional, S.A.B. de C.V. (LABB.MX) is currently trading at 12.32 MXN. Market analysts have a consensus price target of 26.20 MXN. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 10.07. This relatively low multiple may signal that Genomma Lab Internacional, S.A.B. de C.V. is undervalued compared to historical market norms.
Earnings Schedule: Genomma Lab Internacional, S.A.B. de C.V. is expected to release its next earnings report on Oct. 21, 2026. The market consensus estimate for Forward EPS is 2.51.
For income investors, Genomma Lab Internacional, S.A.B. de C.V. pays a dividend yield of 4.90%. With a payout ratio of 48%, the dividend appears sustainable.
Investor FAQ
Does Genomma Lab Internacional, S.A.B. de C.V. pay a dividend?
Yes, it pays an annual dividend of 0.80 MXN (4.90% yield).
What asset class is Genomma Lab Internacional, S.A.B. de C.V.?
Genomma Lab Internacional, S.A.B. de C.V. is classified as a Stock. You can compare it against 3 other assets in the "Related Symbols" list on this page.
When is the next earnings date?
The next earnings date is projected to be Oct. 21, 2026. The company currently has a trailing EPS of 1.65.
Company Profile
Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and improvement products, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, infant nutrition, and others. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.
| Year | Total Dividends |
|---|---|
| ▸2027 |
0.35 MXN
|
| June 30, 2027 (estimated) | 0.1534 |
| March 15, 2027 (estimated) | 0.2000 |
| ▸2026 |
0.81 MXN
|
| Dec. 23, 2026 (estimated) | 0.2040 |
| Sept. 18, 2026 (estimated) | 0.2040 |
| June 29, 2026 | 0.2000 |
| March 30, 2026 | 0.2000 |
| ▸2025 |
0.80 MXN
|
| Dec. 23, 2025 | 0.2000 |
| Sept. 18, 2025 | 0.2000 |
| June 30, 2025 | 0.2000 |
| March 13, 2025 | 0.2000 |
| ▸2024 |
0.80 MXN
|
| Dec. 17, 2024 | 0.2000 |
| Sept. 13, 2024 | 0.2000 |
| June 20, 2024 | 0.2000 |
| March 21, 2024 | 0.1961 |
| ▸2023 |
0.59 MXN
|
| Dec. 22, 2023 | 0.1961 |
| Sept. 28, 2023 | 0.1961 |
| June 5, 2023 | 0.1961 |
| ▸2022 |
0.76 MXN
|
| Nov. 11, 2022 | 0.3817 |
| June 6, 2022 | 0.3817 |
| ▸2021 |
1.15 MXN
|
| Dec. 10, 2021 | 0.3817 |
| Dec. 1, 2021 | 0.7634 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Genomma Lab Internacional, S.A.B. de C.V. | Jun 29, 2026 | Paid | 0.2 MXN |
| Genomma Lab Internacional, S.A.B. de C.V. | Mar 30, 2026 | Paid | 0.2 MXN |
| Genomma Lab Internacional, S.A.B. de C.V. | Dec 23, 2025 | Paid | 0.2 MXN |
| Split Date | Split Ratio to 1 |
|---|---|
| Aug. 2, 2010 | 2:1 |
Community Discussion